Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Angiodynamics (ANGO) over the last 14 years, with Q4 2025 value amounting to $17.1 million.

  • Angiodynamics' Other Non-Current Liabilities rose 4387.92% to $17.1 million in Q4 2025 from the same period last year, while for Nov 2025 it was $17.1 million, marking a year-over-year increase of 4387.92%. This contributed to the annual value of $16.9 million for FY2025, which is 513.75% up from last year.
  • As of Q4 2025, Angiodynamics' Other Non-Current Liabilities stood at $17.1 million, which was up 4387.92% from $14.2 million recorded in Q3 2025.
  • Angiodynamics' Other Non-Current Liabilities' 5-year high stood at $17.4 million during Q1 2025, with a 5-year trough of $2.6 million in Q4 2023.
  • Its 5-year average for Other Non-Current Liabilities is $12.5 million, with a median of $14.9 million in 2021.
  • Per our database at Business Quant, Angiodynamics' Other Non-Current Liabilities tumbled by 7131.83% in 2023 and then surged by 35553.42% in 2024.
  • Over the past 5 years, Angiodynamics' Other Non-Current Liabilities (Quarter) stood at $16.5 million in 2021, then tumbled by 45.15% to $9.1 million in 2022, then tumbled by 71.32% to $2.6 million in 2023, then skyrocketed by 355.53% to $11.9 million in 2024, then soared by 43.88% to $17.1 million in 2025.
  • Its Other Non-Current Liabilities was $17.1 million in Q4 2025, compared to $14.2 million in Q3 2025 and $16.9 million in Q2 2025.